Australia Markets closed

Acadia Healthcare Company, Inc. (ACHC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
31.49-0.26 (-0.82%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 52.8B
Enterprise value 36.31B
Trailing P/E 26.22
Forward P/E 112.65
PEG ratio (5-yr expected) 11.59
Price/sales (ttm)0.91
Price/book (mrq)1.11
Enterprise value/revenue 32.04
Enterprise value/EBITDA 611.84

Trading information

Stock price history

Beta (5Y monthly) 1.43
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 335.30
52-week low 311.09
50-day moving average 327.63
200-day moving average 326.33

Share statistics

Avg vol (3-month) 3648.89k
Avg vol (10-day) 3527.74k
Shares outstanding 588.96M
Float 81.69M
% held by insiders 11.55%
% held by institutions 1119.21%
Shares short (14 Jul 2020) 48.23M
Short ratio (14 Jul 2020) 411.89
Short % of float (14 Jul 2020) 413.25%
Short % of shares outstanding (14 Jul 2020) 49.25%
Shares short (prior month 14 Jun 2020) 48.9M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 331 Oct 2011

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020

Profitability

Profit margin 3.42%
Operating margin (ttm)11.87%

Management effectiveness

Return on assets (ttm)3.37%
Return on equity (ttm)4.33%

Income statement

Revenue (ttm)3.09B
Revenue per share (ttm)35.22
Quarterly revenue growth (yoy)-4.90%
Gross profit (ttm)1.27B
EBITDA 532.38M
Net income avi to common (ttm)105.85M
Diluted EPS (ttm)1.20
Quarterly earnings growth (yoy)-14.70%

Balance sheet

Total cash (mrq)211.94M
Total cash per share (mrq)2.38
Total debt (mrq)3.68B
Total debt/equity (mrq)145.06
Current ratio (mrq)1.16
Book value per share (mrq)28.48

Cash flow statement

Operating cash flow (ttm)469.16M
Levered free cash flow (ttm)125.51M